Wegovy® is now accessible to eligible Medicare beneficiaries living with obesity through Medicare GLP-1 Bridge

Starting today, eligible Medicare patients living with obesity can access Wegovy® (semaglutide) injection and pill for a $50 monthly copay Wegovy® offers adults living with obesity significant weight loss, along with diet and exercise, and is FDA-approved to lower the risk of major...